Drugs Used for Weight Loss Could Cost Americans Much More Than People in Peer Countries

In addition to having the highest obesity rates, the U.S is currently facing significantly higher prices for several major drugs used for weight loss and other health needs, according to a new KFF analysis of the list prices for semaglutide and tirzepatide drugs. Ozempic, which has been approved in the U.S. for diabetes, is moreMore

Read the full post on Reports on Health Insurance and Health Care Costs from the Kaiser Family Foundation